Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia

Abstract

The development of acute myelogenous leukemia (AML), which is characterized by a block of myeloid differentiation, is a multi-step process that involves several genetic abnormalities, but the molecular mechanisms by which these genetic alterations cooperate in leukemogenesis are poorly understood. The human chronic myelogenous leukemia (CML) is a model for multi-step leukemogenesis. BCR-ABL, a constitutively active tyrosine kinase, is a fusion protein generated by the t(9;22)(q34;q11) translocation found in the vast majority of CML patients. BCR-ABL efficiently induces a myeloproliferative disorder (MPD) in mice, but progression to CML blast phase requires additional mutations. The AML1/MDS1/EVI1 (AME) transcription factor fusion protein, is a product of the human t(3;21)(q26;q22) translocation found as a secondary mutation in some cases of CML during the blast phase. We have previously shown that AME can induce an AML in mice but with a greatly extended latency, suggesting a requirement for additional mutations. Here we demonstrate that AME alone does not block myeloid differentiation in vivo during the 4-month pre-leukemia stage, yet co-expression of BCR-ABL and AME in mice can block myeloid differentiation and rapidly induce an AML. Our results suggest that block of myeloid differentiation and induction of AML involves cooperation between mutations that dysregulate protein tyrosine kinase signaling and those that disrupt hematopoietic gene transcription.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Ahuja HG, Foti A, Bar-Eli M, Cline MJ . 1990 Blood 75: 1684–1690

  • Castilla LH, Garrett L, Adya N, Orlic D, Dutra A, Anderson S, Owens J, Eckhaus M, Bodine D, Liu PP . 1999 Nat. Genet. 23: 144–146

  • Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M, Marin-Padilla M, Collins FS, Wynshaw-Boris A, Liu PP . 1996 Cell 87: 687–696

  • Cuenco GM, Nucifora G, Ren R . 2000 Proc. Natl. Acad. Sci. USA 97: 1760–1765

  • Daley GQ, Van Etten RA, Baltimore D . 1990 Science 247: 824–830

  • Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM . 1999 N. Engl. J. Med. 341: 164–172

  • Fialkow PJ, Janssen JW, Bartram CR . 1991 Blood 77: 1415–1417

  • Frederickson TN, Harris AW . 2000 Atlas of Mouse Hematopathology Gordon and Breach, Amsterdam, The Netherlands

    Google Scholar 

  • Goldman JM . 1997 Curr. Opin. Hematol. 4: 277–285

  • Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN, Sawyers CL . 2001 Science 293: 876–880

  • Gross AW, Zhang X, Ren R . 1999 Mol. Cell. Biol. 19: 6918–6928

  • Hao SX, Ren R . 2000 Mol. Cell. Biol. 20: 1149–1161

  • Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P . 2000 Hematology: Basic Principles and Practice, 3rd edn Churchill Livingstone, Philadelphia, Pennsylvania

  • Horiike S, Yokota S, Nakao M, Iwai T, Sasai Y, Kaneko H, Taniwaki M, Kashima K, Fujii H, Abe T, Misawa S . 1997 Leukemia 11: 1442–1446

  • Heuttner CS, Zhang P, Van Etten RA, Tenen DG . 2000 Nat. Genet. 24: 57–60

  • Jacobs A . 1991 Leukemia 5: 277–282

  • Kiyoi H, Towatari M, Yokota S, Hamaguchi M, Ohno R, Saito H, Naoe T . 1998 Leukemia 12: 1333–1337

  • Kreider BL, Orkin SH, Ihle JN . 1993 Proc. Natl. Acad. Sci. USA 90: 6454–6458

  • Li S, Ilaria Jr RL, Million RP, Daley GQ, Van Etten RA . 1999 J. Exp. Med. 189: 1399–1412

  • Louz D, van den Broek M, Verbakel S, Vankan Y, van Lom K, Joosten M, Meijer D, Lowenberg B, Delwel R . 2000 Leukemia 14: 1876–1884

  • Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H . 1994 EMBO J. 13: 504–510

  • Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, Sonoda Y, Fujimoto T, Misawa S . 1996 Leukemia 10: 1911–1918

  • Neubauer A, Dodge RK, George SL, Davey FR, Silver RT, Schiffer CA, Mayer RJ, Ball ED, Wurster-Hill D, Bloomfield CD . 1994 Blood 83: 1603–1611

  • Niki M, Okada H, Takano H, Kuno J, Tani K, Hibino H, Asano S, Ito Y, Satake M, Noda T . 1997 Proc. Natl. Acad. Sci. USA 94: 5697–5702

  • Nucifora G . 1997 Leukemia 11: 2022–2031

  • Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle JN, Rowley JD . 1994 Proc. Natl. Acad. Sci. USA 91: 4004–4008

  • Nucifora G, Birn DJ, Espinosa RD, Erickson P, LeBeau MM, Roulston D, McKeithan TW, Drabkin H, Rowley JD . 1993 Blood 81: 2728–2734

  • Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, van Deursen JM, Harada H, Downing JR . 1998 Blood 91: 3134–3143

  • Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR . 1996 Cell 84: 321–330

  • Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D . 1998 Blood 92: 3780–3792

  • Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, Grassilli E, Lozzo RV, Cooper DR, Calabretta B . 1998 EMBO J. 17: 4442–4455

  • Sawyers CL . 1999 N. Engl. J. Med. 340: 1330–1340

  • Sood R, Talwar-Trikha A, Chakrabarti SR, Nucifora G . 1999 Leukemia 13: 348–357

  • Tanaka A, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y, Shibata Y, Hirai H . 1995a Mol. Cell. Biol. 15: 2383–2392

  • Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Nishida J, Shibata Y, Yazaki Y, Hirai H . 1995b EMBO J. 14: 341–350

  • Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X, Bushweller JH, Bories JC, Alt FW, Ryan G, Liu PP, Wynshaw-Boris A, Binder M, Marin-Padilla M, Sharpe AH, Speck NA . 1996 Cell 87: 697–708

  • Westendorf JJ, Yamamoto CM, Lenny N, Downing JR, Selsted ME, Hiebert SW . 1998 Mol. Cell. Biol. 18: 322–333

  • Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S, Asou N, Kuriyama K, Yagasaki F, Shimazaki C, Akiyama H, Saito K, Nishimura M, Motoji T, Shinagawa K, Takeshita A, Saito H, Ueda R, Ohno R, Naoe T . 2001 Blood 97: 2434–2439

  • Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marin-Padilla M, Tenen DG, Speck NA, Zhang DE . 1997 Nat. Genet. 15: 303–306

  • Yokota S, Kiyoi H, Nakao M, Iwai T, Misawa S, Okuda T, Sonoda Y, Abe T, Kahsima K, Matsuo Y, Naoe T . 1997 Leukemia 11: 1605–1609

  • Yuan Y, Zhou L, Miyamoto T, Iwasaki H, Harakawa N, Hetherington CJ, Burel SA, Lagasse E, Weissman IL, Akashi K, Zhang DE . 2001 Proc. Natl. Acad. Sci. USA 98: 10398–10403

  • Zhang X, Ren R . 1998 Blood 92: 3829–3840

Download references

Acknowledgements

We are grateful to Jennifer Joyce for technical assistance and to Mike Jennings and Glenn Paradis for assistance and advice in flow cytometry cell sorting. GM Cuenco is supported by the National Institutes of Health Training Grant GM07122. R Ren is a recipient of the Leukemia Society of America Scholar Award.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruibao Ren.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cuenco, G., Ren, R. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia. Oncogene 20, 8236–8248 (2001). https://doi.org/10.1038/sj.onc.1205095

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205095

Keywords

This article is cited by

Search

Quick links